Who is sponsoring MEnD-AKI?

MEnD-AKI is sponsored by University of Pittsburgh.

What condition does MEnD-AKI study?

MEnD-AKI studies Acute Kidney Injury.

What drugs are being tested in MEnD-AKI?

Interventions: Level A, Level B, Passive Alert.

What is the status of MEnD-AKI?

MEnD-AKI is currently COMPLETED.

Last reviewed 2025-09-12 · How we verify

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury (MEnD-AKI)

NCT06264752 NA COMPLETED

This study is a randomized controlled trial at eight hospitals within the University of Pittsburgh Medical Center-UPMC system. The project will assess the efficacy of a clinical surveillance system augmented with near real-time predictive analytics to support a pharmacist-led intervention delivered to attending physicians (primary service) to reduce the progression and complications of drug-associated acute kidney injury (D-AKI) in hospitalized (non-ICU) adults.

Details

Lead sponsor	University of Pittsburgh
Phase	NA
Status	COMPLETED
Enrolment	698
Start date	Thu Feb 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Acute Kidney Injury

Interventions

Level A
Level B
Passive Alert

Countries

United States